otc.pharmaceutical-business-review.comMarketing & Sales Archives - Pharmaceutical Business review

Pharmaceutical Business review Marketing & Sales Archives - Pharmaceutical Business review Pharmaceutical Business review is using cookies Continue Learn More Close ☰ Search × HomeAdd Company Advertise with us Contact us Events Suplpiers News Clinical Trials Drug Discovery Packaging & Supply Chain Production & Sales Regulation Advertise With Us Advertise on our extensive network of industry websites and newsletters. Get the PBR newsletter Sign up to our free email to get all the latest PBR news. Home Drug Discovery Drug Discovery Research & Development Pre-clinical Studies Research & Development PharmaLogic launches new radiopharmaceutical facility in New York, US Research & Development Manufacturing Latus Bio secures $54m for CNS gene therapy development Research & Development Clinical Trials Clinical Trials Patient Enrollment Human Trials Patient Enrollment US FDA approves Avacta Group’s IND application for AVA6000 Clinical Trials Patient Enrollment AM-Pharma enrols first patients in Covid-19 phase III trial Clinical Trials Patient Enrollment Regulation Regulation Drug Filing Approvals Rejections Marketing Authorisation Patents Lawsuits Drug Filing FDA accepts BLA for BMS’ subcutaneous nivolumab to treat solid tumours Drug Filing Oncology USFDA accepts NextPoint Therapeutics’s IND for NPX887 Drug Filing Production & Sales Production & Sales Manufacturing Launches Recalls Marketing & Sales Manufacturing PharmaLogic launches new radiopharmaceutical facility in New York, US Research & Development Manufacturing IMA Life to build new pharma freeze-drying equipment production site Manufacturing Pharmaceuticals and Healthcare Packaging & Supply Chain Packaging & Supply Chain Packaging Cold Chain Distribution Storage Packaging Gerresheimer Packaging PCI Pharma announces bottling line expansion at Rockford site Packaging & Supply Chain Packaging Suppliers Suppliers A-Z Suppliers Products & Services Videos White Papers No data found EventsRegister Log In Production & Sales - Marketing & Sales 26 Oct 2023 Marketing & Sales Mithra signs license agreement with Searchlight for Donesta in Canada By PBR Staff Writer Mithra Pharmaceuticals has entered into a license and supply agreement with Searchlight Pharma for the Canadian rights to Donesta. 11 Oct 2023 Marketing & Sales Y.S.P. Industries to market TaiGen’s new drug in Malaysia and Singapore By PBR Staff Writer Y.S.P. Industries has entered into an exclusive licensing agreement to develop and market TaiGen Biopharmaceuticals Holdings’ (TaiGen) new drug in Malaysia and Singapore. 25 Sep 2023 Marketing & Sales Lupin acquires five brands and associated trademark rights from Menarini By PBR Staff Writer Indian pharmaceutical firm Lupin has entered into an agreement to acquire five brands along with associated trademark rights from the units of MenariniA. Menarini India Private Limited and A. Menarini Asia-Pacific Holdings. 14 Jul 2023 Marketing & Sales TheracosBio’s commercialises type 2 diabetes oral tablet By PBR Staff Writer TheracosBio has announced the commercial availability of Brenzavvy (bexagliflozin) oral tablet for the treatment of adults with type 2 diabetes by prescription through the Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs). 13 Jul 2023 Marketing & Sales Astellas Pharma completes acquisition of Iveric Bio By PBR Staff Writer Astellas Pharma, through its indirect wholly owned subsidiary, Berry Merger Sub, has completed the acquisition of Iveric Bio. 25 May 2023 Marketing & Sales Alvotech partners with Advanz for biosimilars commercialisation in Europe By PBR Staff Writer Alvotech and Advanz Pharma have extended their strategic partnership for the supply and commercialisation of five biosimilars in Europe. 30 Mar 2023 Production & Sales Marketing & Sales Navamedic announces $7.2m cash offer for Sensidose acquisition By PBR Staff Writer Nordic pharma company Navamedic ASA has offered $7.2m (SEK75m) to purchase all shares in Sweden-based pharmaceutical firm Sensidose AB. 29 Mar 2023 Production & Sales Marketing & Sales Drug Manufacturing OncoVent signs agreement with Orient EuroPharma for oregovomab By PBR Staff Writer Shenzhen Hepalink Pharmaceutical Group’s subsidiary OncoVent has entered into a licence and distribution agreement with Orient EuroPharma (OEP) for the immunotherapeutic drug candidate, oregovomab. 08 Sep 2021 Research & Development Marketing & Sales Adaptimmune and Genentech partner on allogeneic cell therapies By vbandhakavi Adaptimmune Therapeutics has signed a strategic partnership and licence agreement with Roche Group member, Genentech, for the development and commercialisation of allogeneic cell therapies across several cancer indications. 15 Apr 2021 Neurology Manufacturing SciNeuro and Eli Lilly sign exclusive license agreement for alpha-synuclein in Greater China By PBR Staff Writer Biopharmaceutical company SciNeuro Pharmaceuticals has signed an exclusive license agreement with Eli Lilly and Company for the development and commercialisation of alpha-synuclein targeted antibody therapies in Greater China.Advertise with us Contact us PRIVACY POLICY TERMS AND CONDITIONS © PBR 2024. Part of Progressive Trade Media Ltd. Lost Password Back ⟶ Login Register Get new password Lost Password? Login Registration is...